⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4315969 | 0.83 | — | — | |
| SCHEMBL3032 | 0.71 | ALDH1A1 (0.44) | — | |
| SCHEMBL196535 | 0.70 | — | — | |
| SCHEMBL3483155 | 0.69 | — | — | |
| SCHEMBL1694903 | 0.69 | CLK1 (0.40) | — | |
| SCHEMBL6538293 | 0.68 | — | — | |
| SCHEMBL158440 | 0.68 | KDM4E (0.32) | — | |
| SCHEMBL3835810 | 0.67 | — | — | |
| SCHEMBL81548 | 0.67 | EGFR (0.52) | — | |
| SCHEMBL2894880 | 0.66 | MALT1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4713736-B2 | — | — | 2011-06-29 | — | — | JP | claimed |
| US-6884477-B1 | Electroluminescence device using liquid crystal compound | CANON KABUSHIKI KAISHA (JP) | 2005-04-26 | — | — | US | claimed |
| EP-1147162-B1 | FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE | CLARIANT GMBH (DE) | 2004-06-09 | — | — | EP | claimed |
| US-6746731-B1 | ACHIEVES VERY HIGH MAXIMUM TRANSMISSION AND VERY HIGH CONTRAST AND CONSTANT THRESHOLD VOLTAGE OVER BROAD TEMPERATURE RANGE | CLARIANT GMBH (DE) | 2004-06-08 | — | — | US | claimed |
| EP-1086194-B1 | MONOSTABLE FERROELECTRIC ACTIVE MATRIX DISPLAY | AVENTIS RES & TECH GMBH & CO (DE) | 2003-05-21 | — | — | EP | claimed |
| US-6551668-B1 | Monodomain liquid crystal layer with an unambiguously defined direction of the layer normal z of the smectite phase wherein the layer normal z and the preferential direction n of the nematic or cholesteric phase (N* phase) form an angle of >/= 5 | AVENTIS RESEARCH & TECHNOLOGIES (DE) | 2003-04-22 | — | — | US | claimed |
| US-6482479-B1 | Active matrix displays having high contrast values | CLARIANT INTERNATIONAL LTD. (CH) | 2002-11-19 | — | — | US | claimed |
| JP-2002532613-A | — | — | 2002-10-02 | — | — | JP | claimed |
| EP-1198537-A1 | HIGH-CONTRAST ACTIVE MATRIX DISPLAYS | CLARIANT INTERNATIONAL LTD. (CH) | 2002-04-24 | — | — | EP | claimed |
| EP-1147162-A1 | FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE | Clariant GmbH (DE) | 2001-10-24 | — | — | EP | claimed |
| EP-1086194-A1 | MONOSTABLE FERROELECTRIC ACTIVE MATRIX DISPLAY | Aventis Research & Technologies GmbH & Co. KG. (DE) | 2001-03-28 | — | — | EP | claimed |
| WO-2000069987-A1 | HIGH-CONTRAST ACTIVE MATRIX DISPLAYS | CLARIANT INTERNATIONAL LTD. (CH) | 2000-11-23 | — | — | WO | claimed |
| WO-2000036054-A1 | FERROELECTRIC ACTIVE MATRIX DISPLAYS WITH WIDE OPERATING TEMPERATURE RANGE | CLARIANT GMBH (DE) | 2000-06-22 | — | — | WO | claimed |
| WO-1999064538-A1 | MONOSTABLE FERROELECTRIC ACTIVE MATRIX DISPLAY | AVENTIS RESEARCH & TECHNOLOGIES GMBH & CO. KG (DE) | 1999-12-16 | — | — | WO | claimed |
| US-8940375-B2 | Liquid-crystal display | MERCK PATENT GMBH (DE) | 2015-01-27 | — | — | US | disclosed |
| US-20100188618-A1 | LIQUID-CRYSTAL DISPLAY | MERCK Patent Gesellschaft mit beschränkter Haftung (DE) | 2010-07-29 | — | — | US | disclosed |
| US-7566781-B2 | Imidazopyridine compound | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2009-07-28 | — | — | US | disclosed |
| US-5541339-A | ANTITUMOR AGENTS | THE UPJOHN COMPANY (US) | 1996-07-30 | — | — | US | disclosed |
| WO-1990002746-A1 | NOVEL CC-1065 ANALOGS HAVING TWO CPI SUBUNITS | THE UPJOHN COMPANY (US) | 1990-03-22 | — | — | WO | disclosed |
| EP-0359454-A1 | Novel CC-1065 analogs having two CPI subunits | THE UPJOHN COMPANY (US) | 1990-03-21 | — | — | EP | disclosed |